Paper20008650
Pittsburgh compound B imaging and prediction of progression from cognitive normality to symptomatic Alzheimer disease.
Morris JC and 8 others. Arch Neurol, 2009. Cited by 364 papers, by iCite.
Cite this record
ConductScience Library. Pittsburgh compound B imaging and prediction of progression from cognitive normality to symptomatic Alzheimer disease. Papers, record 20008650. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/20008650
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics18
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Alzheimer Disease | Major topic |
| Aniline Compounds | Major topic |
| Carbon Radioisotopes | Major topic |
| Cognition | Major topic |
| Cognition Disorders | Major topic |
| Thiazoles | Major topic |
| Aged | |
| Aged, 80 and over | |
| Cohort Studies | |
| Disease Progression | |
| Female | |
| Follow-Up Studies | |
| Humans | |
| Longitudinal Studies | |
| Male | |
| Middle Aged | |
| Positron-Emission Tomography | |
| Predictive Value of Tests |
Source PubMed
Grants9
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| P01AG026276 | NIA NIH HHS | United States | P01AG026276 | PubMed and NIH | NIH RePORTER |
| P01 AG026276 | NIA NIH HHS | United States | P01AG026276 | PubMed and NIH | NIH RePORTER |
| UL1 RR024992 | NCRR NIH HHS | United States | UL1RR024992 | PubMed and NIH | NIH RePORTER |
| P01AG03991 | NIA NIH HHS | United States | P01AG003991 | PubMed and NIH | NIH RePORTER |
| 1UL1RR024992 | NCRR NIH HHS | United States | UL1RR024992 | PubMed and NIH | NIH RePORTER |
| UL1 TR000448 | NCATS NIH HHS | United States | UL1TR000448 | PubMed and NIH | NIH RePORTER |
| P50AG05681 | NIA NIH HHS | United States | P50AG005681 | PubMed and NIH | NIH RePORTER |
| P01 AG003991 | NIA NIH HHS | United States | P01AG003991 | PubMed and NIH | NIH RePORTER |
| P50 AG005681 | NIA NIH HHS | United States | P50AG005681 | PubMed and NIH | NIH RePORTER |
References53
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 19523877 | Prevalence and prognostic value of CSF markers of Alzheimer's disease pathology in patients with subjective cognitive impairment or mild cognitive impairment in the DESCRIPA study: a prospective cohort study. | Lancet Neurol | 2009 | https://conductscience.org/library/papers/19523877 | PubMed |
| 2 | 14676043 | Cerebrospinal fluid tau and beta-amyloid: how well do these biomarkers reflect autopsy-confirmed dementia diagnoses? | Arch Neurol | 2003 | https://conductscience.org/library/papers/14676043 | PubMed |
| 3 | 16894109 | Longitudinal course and neuropathologic outcomes in original vs revised MCI and in pre-MCI. | Neurology | 2006 | https://conductscience.org/library/papers/16894109 | PubMed |
| 4 | 20186853 | APOE predicts amyloid-beta but not tau Alzheimer pathology in cognitively normal aging. | Ann Neurol | 2010 | https://conductscience.org/library/papers/20186853 | PubMed |
| 5 | 19296504 | Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects. | Ann Neurol | 2009 | https://conductscience.org/library/papers/19296504 | PubMed |
| 6 | 8784228 | Distribution volume ratios without blood sampling from graphical analysis of PET data. | J Cereb Blood Flow Metab | 1996 | https://conductscience.org/library/papers/8784228 | PubMed |
| 7 | 17499392 | PET imaging of amyloid deposition in patients with mild cognitive impairment. | Neurobiol Aging | 2008 | https://conductscience.org/library/papers/17499392 | PubMed |
| 8 | 17502554 | Imaging beta-amyloid burden in aging and dementia. | Neurology | 2007 | https://conductscience.org/library/papers/17502554 | PubMed |
| 9 | 14656067 | Neuropathology of cognitively normal elderly. | J Neuropathol Exp Neurol | 2003 | https://conductscience.org/library/papers/14656067 | PubMed |
| 10 | 20008664 | Absence of Pittsburgh compound B detection of cerebral amyloid beta in a patient with clinical, cognitive, and cerebrospinal fluid markers of Alzheimer disease: a case report. | Arch Neurol | 2009 | https://conductscience.org/library/papers/20008664 | PubMed |
| 11 | 8232972 | The Clinical Dementia Rating (CDR): current version and scoring rules. | Neurology | 1993 | https://conductscience.org/library/papers/8232972 | PubMed |
| 12 | 16488378 | Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study. | Lancet Neurol | 2006 | https://conductscience.org/library/papers/16488378 | PubMed |
| 13 | 10072051 | Tangles and plaques in nondemented aging and "preclinical" Alzheimer's disease. | Ann Neurol | 1999 | https://conductscience.org/library/papers/10072051 | PubMed |
| 14 | 19001171 | Frequent amyloid deposition without significant cognitive impairment among the elderly. | Arch Neurol | 2008 | https://conductscience.org/library/papers/19001171 | PubMed |
| 15 | 1202204 | "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. | J Psychiatr Res | 1975 | https://conductscience.org/library/papers/1202204 | PubMed |
| 16 | 14872024 | Higher atrophy rate of entorhinal cortex than hippocampus in AD. | Neurology | 2004 | https://conductscience.org/library/papers/14872024 | PubMed |
| 17 | 19376612 | Neuropathology of nondemented aging: presumptive evidence for preclinical Alzheimer disease. | Neurobiol Aging | 2009 | https://conductscience.org/library/papers/19376612 | PubMed |
| 18 | 19475670 | Amyloid imaging in mild cognitive impairment subtypes. | Ann Neurol | 2009 | https://conductscience.org/library/papers/19475670 | PubMed |
| 19 | 19001165 | Alzheimer disease and cognitive reserve: variation of education effect with carbon 11-labeled Pittsburgh Compound B uptake. | Arch Neurol | 2008 | https://conductscience.org/library/papers/19001165 | PubMed |
| 20 | 20049742 | Cerebrospinal fluid tau and ptau(181) increase with cortical amyloid deposition in cognitively normal individuals: implications for future clinical trials of Alzheimer's disease. | EMBO Mol Med | 2009 | https://conductscience.org/library/papers/20049742 | PubMed |
Cited by238
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 364 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41217839 | Uncovering pathology, subjective cognitive complaints, and sex in early Alzheimer's disease. | J Alzheimers Dis | 2026 | https://conductscience.org/library/papers/41217839 | PubMed |
| 40525437 | Pharmacological Characterization of Ruellia tuberosa Ethanolic Extract in a Rodent Model of Cognitive Impairment. | Recent Adv Inflamm Allergy Drug Discov | 2026 | https://conductscience.org/library/papers/40525437 | PubMed |
| 40496971 | Neuropsychological and clinical variables associated with cognitive trajectories in patients with Alzheimer's disease. | Front Aging Neurosci | 2025 | https://conductscience.org/library/papers/40496971 | PubMed |
| 40327345 | Research Participant Interest in Learning Results of Biomarker Tests for Alzheimer Disease. | JAMA Netw Open | 2025 | https://conductscience.org/library/papers/40327345 | PubMed |
| 40092368 | Uncovering atrophy progression pattern and mechanisms in individuals at risk of Alzheimer's disease. | Brain Commun | 2025 | https://conductscience.org/library/papers/40092368 | PubMed |
| 38514082 | Quantitative Brain Amyloid PET. | J Nucl Med | 2024 | https://conductscience.org/library/papers/38514082 | PubMed |
| 37991017 | Mitochondria-sequestered Aβ renders synaptic mitochondria vulnerable in the elderly with a risk of Alzheimer disease. | JCI Insight | 2023 | https://conductscience.org/library/papers/37991017 | PubMed |
| 37718818 | Serotonin Degeneration and Amyloid-β Deposition in Mild Cognitive Impairment: Relationship to Cognitive Deficits. | J Alzheimers Dis | 2023 | https://conductscience.org/library/papers/37718818 | PubMed |
| 37544835 | Neuropsychiatric Symptoms and Alzheimer Disease Biomarkers Independently Predict Progression to Incident Cognitive Impairment. | Am J Geriatr Psychiatry | 2023 | https://conductscience.org/library/papers/37544835 | PubMed |
| 37371522 | A Truncated 14-Amino-Acid Myelin Protein-Zero-Targeting Peptide for Fluorescence-Guided Nerve-Preserving Surgery. | Biomolecules | 2023 | https://conductscience.org/library/papers/37371522 | PubMed |
| 37315112 | Gut microbiome composition may be an indicator of preclinical Alzheimer's disease. | Sci Transl Med | 2023 | https://conductscience.org/library/papers/37315112 | PubMed |
| 37213538 | Safety and efficacy of lecanemab for Alzheimer's disease: a systematic review and meta-analysis of randomized clinical trials. | Front Aging Neurosci | 2023 | https://conductscience.org/library/papers/37213538 | PubMed |
| 37202518 | Detection and treatment of Alzheimer's disease in its preclinical stage. | Nat Aging | 2023 | https://conductscience.org/library/papers/37202518 | PubMed |
| 36419201 | Adverse driving behaviors increase over time as a function of preclinical Alzheimer's disease biomarkers. | Alzheimers Dement | 2023 | https://conductscience.org/library/papers/36419201 | PubMed |
| 35978440 | C5aR1 antagonism alters microglial polarization and mitigates disease progression in a mouse model of Alzheimer's disease. | Acta Neuropathol Commun | 2022 | https://conductscience.org/library/papers/35978440 | PubMed |
| 35867858 | Preclinical Alzheimer's disease biomarkers accurately predict cognitive and neuropathological outcomes. | Brain | 2022 | https://conductscience.org/library/papers/35867858 | PubMed |
| 35303111 | Adverse driving behaviors are associated with sleep apnea severity and age in cognitively normal older adults at risk for Alzheimer's disease. | Sleep | 2022 | https://conductscience.org/library/papers/35303111 | PubMed |
| 35233522 | Regional amyloid correlates of cognitive performance in ageing and mild cognitive impairment. | Brain Commun | 2022 | https://conductscience.org/library/papers/35233522 | PubMed |
| 34897083 | Quantitative Gradient Echo MRI Identifies Dark Matter as a New Imaging Biomarker of Neurodegeneration that Precedes Tisssue Atrophy in Early Alzheimer's Disease. | J Alzheimers Dis | 2022 | https://conductscience.org/library/papers/34897083 | PubMed |
| 34617016 | Amyloid-driven disruption of default mode network connectivity in cognitively healthy individuals. | Brain Commun | 2021 | https://conductscience.org/library/papers/34617016 | PubMed |
Genes3
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| APOE | 348 | PubTator's text mining | https://conductscience.org/library/genes/348 | NCBI Gene |
| APP | 351 | PubTator's text mining | https://conductscience.org/library/genes/351 | NCBI Gene |
| MAPT | 4137 | PubTator's text mining | https://conductscience.org/library/genes/4137 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/20008650
GET https://conductscience.org/api/papers/v1/20008650/references?page=2